Back to Neurology
NeurologyvModified (Meyer 2002)Evidence-Based

Modified NIH Stroke Scale/Score (mNIHSS)

Shortened, validated version of NIH Stroke Scale for quantifying stroke severity with improved interrater reliability

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
mnihss score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Modified NIH Stroke Scale/Score (mNIHSS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of points from 11 parameters: Orientation (0-2), Commands (0-2), Eye Movements (0-2), Visual Fields (0-3), Left/Right Arm Motor (0-4 each), Left/Right Leg Motor (0-4 each), Sensation (0-1), Language (0-3), Extinction/Neglect (0-2). Range: 0-31 points.

Clinical Pearls & Practice Notes

  • Shortened version of original NIHSS with improved interrater reliability
  • Removes redundant items and poorly reliable components from original NIHSS
  • Maximum score 31 points (vs 42 for original NIHSS)
  • Takes approximately 6 minutes to complete (vs 7-10 minutes for NIHSS)
  • Better reliability when used via telemedicine or abstracted from records
  • Items removed: Level of consciousness alertness (1A), ataxia (7), and dysarthria (10)
  • Facial weakness combined with other motor assessments for efficiency
  • Lower scores indicate better neurological function and outcomes
  • Validated for use in clinical trials and acute stroke assessment
  • Can predict functional outcomes and mortality after stroke
  • Useful for monitoring neurological changes over time
  • Helps guide treatment decisions including tPA administration

Evidence & Literature Citations

  1. Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke. 2002 Feb;33(2):328-33. doi: 10.1161/hs0202.102318.
  2. Meyer BC, Lyden PD. The modified National Institutes of Health Stroke Scale: its time has come. Int J Stroke. 2009 Aug;4(4):267-73. doi: 10.1111/j.1747-4949.2009.00294.x.
  3. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994 Nov;25(11):2220-6. doi: 10.1161/01.str.25.11.2220.
  4. Bruno A, Shah N, Lin C, Close B, Hess DC, Davis K, Baute V, Switzer JA, Waller JL, Nichols FT. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke. 2010 May;41(5):1048-50. doi: 10.1161/STROKEAHA.109.571562.

Score Interpretation Ranges

Minor Stroke0 – 4 pts

Minimal neurological deficit

Moderate Stroke5 – 15 pts

Moderate neurological deficit

Moderate-Severe Stroke16 – 20 pts

Moderate to severe neurological deficit

Severe Stroke21 – 31 pts

Severe neurological deficit

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.